1 – 10 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes
- Contribution to journal › Article
-
Mark
Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Contribution to journal › Article
- 2024
-
Mark
Incidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicentre observational study (AMESI Study)
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
- Contribution to journal › Article
-
Mark
Low-grade inflammation in persons with recently diagnosed type 2 diabetes : The role of abdominal adiposity and putative mediators
- Contribution to journal › Article
-
Mark
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
- Contribution to journal › Article
-
Mark
Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population
- Contribution to journal › Article
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
- Contribution to journal › Article
-
Mark
Cohort profile : the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)—acute coronary syndrome and percutaneous coronary intervention
- Contribution to journal › Article
